Literature DB >> 6122686

Intermediate stages in enzymatic replication of bacteriophage fd duplex DNA.

K Geider, I Bäumel, T F Meyer.   

Abstract

Using purified enzymes, double strand replication of phage fd DNA has been dissected into several intermediate steps. (i) Phage fd gene 2 protein cleaves supercoiled phage fd replicative form at a specific site in the viral strand (Meyer, T. F., Geider, K., Kurz, C., and Schaller, H. (1979) Nature 278, 365-367). (ii) Relaxed covalently closed circular replicative form DNA which is also formed by gene 2 protein as a side product in the initiation reaction preceding replication is converted into supercoils by DNA gyrase. (iii) The enzyme forms a noncovalent complex at the generated nick that is necessary for initiation of subsequent unwinding. (iv) The Escherichia coli rep helicase (rep protein) and E. coli DNA binding protein I unwind the double-stranded DNA. (v) Concomitant DNA replication by E. coli DNA polymerase III holoenzyme results in the formation of rolling circle intermediates. The double-stranded core of the rolling circle remains in an open form, thus allowing continued synthesis during several rounds of replication. (vi) Processing of replicated viral DNA can be subdivided into the cleavage and the circularization of viral single strands. Comparative studies of fd and phi X174 replication in vitro have revealed differences in the kinetics of individual steps besides an apparent contrast in the conformation of rolling circle intermediates in the electron microscopy where fd DNA features extended tails rather than looped-back structures observed for phi X174 DNA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6122686

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  The nicking endonuclease N.BstNBI is closely related to type IIs restriction endonucleases MlyI and PleI.

Authors:  L S Higgins; C Besnier; H Kong
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

2.  DNA helicase from mammalian mitochondria.

Authors:  G L Hehman; W W Hauswirth
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

3.  A single amino acid substitution reduces the superhelicity requirement of a replication initiator protein.

Authors:  A Higashitani; D Greenstein; K Horiuchi
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

4.  Escherichia coli helicase II (UvrD) protein initiates DNA unwinding at nicks and blunt ends.

Authors:  G T Runyon; D G Bear; T M Lohman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 5.  Multiregulatory element of filamentous bacteriophages.

Authors:  N D Zinder; K Horiuchi
Journal:  Microbiol Rev       Date:  1985-06

6.  Mutational mechanisms by which an inactive replication origin of bacteriophage M13 is turned on are similar to mechanisms of activation of ras proto-oncogenes.

Authors:  M H Kim; D S Ray
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

7.  Integration host factor interacts with the DNA replication enhancer of filamentous phage f1.

Authors:  D Greenstein; N D Zinder; K Horiuchi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

8.  Characterization of functionally important sites in the bacteriophage Mu transposase protein.

Authors:  P I Ulycznyj; F Forghani; M S DuBow
Journal:  Mol Gen Genet       Date:  1994-02

9.  Interaction of Rep and DnaB on DNA.

Authors:  John Atkinson; Milind K Gupta; Peter McGlynn
Journal:  Nucleic Acids Res       Date:  2010-10-18       Impact factor: 16.971

10.  Various mutations compensate for a deleterious lacZα insert in the replication enhancer of M13 bacteriophage.

Authors:  Emily M Zygiel; Karen A Noren; Marta A Adamkiewicz; Richard J Aprile; Heather K Bowditch; Christine L Carroll; Maria Abigail S Cerezo; Adelle M Dagher; Courtney R Hebert; Lauren E Hebert; Gloria M Mahame; Stephanie C Milne; Kelly M Silvestri; Sara E Sutherland; Alexandria M Sylvia; Caitlyn N Taveira; David J VanValkenburgh; Christopher J Noren; Marilena Fitzsimons Hall
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.